These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 2385830)
1. Anti-human factor IX monoclonal antibodies specific for calcium ion-induced conformations. Sugo T; Mizuguchi J; Kamikubo Y; Matsuda M Thromb Res; 1990 Jun; 58(6):603-14. PubMed ID: 2385830 [TBL] [Abstract][Full Text] [Related]
2. A monoclonal antibody to factor IX that inhibits the factor VIII:Ca potentiation of factor X activation. Bajaj SP; Rapaport SI; Maki SL J Biol Chem; 1985 Sep; 260(21):11574-80. PubMed ID: 3930478 [TBL] [Abstract][Full Text] [Related]
3. Modification of the N-terminus of human factor IX by defective propeptide cleavage or acetylation results in a destabilized calcium-induced conformation: effects on phospholipid binding and activation by factor XIa. Wojcik EG; Van Den Berg M; Poort SR; Bertina RM Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):629-36. PubMed ID: 9169594 [TBL] [Abstract][Full Text] [Related]
4. Use of phage display for the generation of human antibodies that neutralize factor IXa function. Suggett S; Kirchhofer D; Hass P; Lipari T; Moran P; Nagel M; Judice K; Schroeder K; Tom J; Lowman H; Adams C; Eaton D; Devaux B Blood Coagul Fibrinolysis; 2000 Jan; 11(1):27-42. PubMed ID: 10691097 [TBL] [Abstract][Full Text] [Related]
5. Identification of residues in the Gla-domain of human factor IX involved in the binding to conformation specific antibodies. Wojcik EG; Cheung WF; van den Berg M; van der Linden IK; Stafford DW; Bertina RM Biochim Biophys Acta; 1998 Jan; 1382(1):91-101. PubMed ID: 9507074 [TBL] [Abstract][Full Text] [Related]
6. An anti-EGF monoclonal antibody that detects intramolecular communication in factor IX. Persson KE; Knobe KE; Stenflo J Biochem Biophys Res Commun; 2001 Sep; 286(5):1039-44. PubMed ID: 11527405 [TBL] [Abstract][Full Text] [Related]
7. Localization of a calcium-dependent epitope to the amino terminal region of the Gla domain of human factor IX. Cheung WF; Stafford DW; Sugo T Thromb Res; 1996 Jan; 81(1):65-73. PubMed ID: 8747521 [TBL] [Abstract][Full Text] [Related]
8. Functional mapping of anti-factor IX inhibitors developed in patients with severe hemophilia B. Christophe OD; Lenting PJ; Cherel G; Boon-Spijker M; Lavergne JM; Boertjes R; Briquel ME; de Goede-Bolder A; Goudemand J; Gaillard S; d'Oiron R; Meyer D; Mertens K Blood; 2001 Sep; 98(5):1416-23. PubMed ID: 11520790 [TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the calcium-stabilized human factor IX Gla domain bound to a conformation-specific anti-factor IX antibody. Huang M; Furie BC; Furie B J Biol Chem; 2004 Apr; 279(14):14338-46. PubMed ID: 14722079 [TBL] [Abstract][Full Text] [Related]
10. Antibody-probed conformational transitions in the protease domain of human factor IX upon calcium binding and zymogen activation: putative high-affinity Ca(2+)-binding site in the protease domain. Bajaj SP; Sabharwal AK; Gorka J; Birktoft JJ Proc Natl Acad Sci U S A; 1992 Jan; 89(1):152-6. PubMed ID: 1729682 [TBL] [Abstract][Full Text] [Related]
11. Profactor IX: the propeptide inhibits binding to membrane surfaces and activation by factor XIa. Bristol JA; Freedman SJ; Furie BC; Furie B Biochemistry; 1994 Nov; 33(47):14136-43. PubMed ID: 7947825 [TBL] [Abstract][Full Text] [Related]
12. Binding properties of the coagulation factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis. Atoda H; Yoshida N; Ishikawa M; Morita T Eur J Biochem; 1994 Sep; 224(2):703-8. PubMed ID: 7925387 [TBL] [Abstract][Full Text] [Related]
13. Factor IX Zutphen: a Cys18-->Arg mutation results in formation of a heterodimer with alpha 1-microglobulin and the inability to form a calcium-induced conformation. Wojcik EG; van den Berg M; van der Linden IK; Poort SR; Cupers R; Bertina RM Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):753-9. PubMed ID: 7487929 [TBL] [Abstract][Full Text] [Related]
14. Conformational changes in an epitope localized to the NH2-terminal region of protein C. Evidence for interaction of protein C domains. Orthner CL; Madurawe RD; Velander WH; Drohan WN; Battey FD; Strickland DK J Biol Chem; 1989 Nov; 264(31):18781-8. PubMed ID: 2478552 [TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies to factor IX: characterization and use in immunoassays for factor IX. Smith KJ; Ono K Thromb Res; 1984 Jan; 33(2):211-24. PubMed ID: 6422579 [TBL] [Abstract][Full Text] [Related]
16. Crystallization of an anti-factor IX antibody and its complex. Shi X; Li Y; Bian C; Zhao G; Huang M Acta Crystallogr D Biol Crystallogr; 2005 Jun; 61(Pt 6):701-3. PubMed ID: 15930624 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody to an epitope on the heavy chain of factor IX missing in three hemophilia-B patients. Thompson AR Blood; 1983 Nov; 62(5):1027-34. PubMed ID: 6194835 [TBL] [Abstract][Full Text] [Related]
18. The N-terminal epidermal growth factor-like domain of coagulation factor IX. Probing its functions in the activation of factor IX and factor X with a monoclonal antibody. Persson KE; Villoutreix BO; Thämlitz AM; Knobe KE; Stenflo J J Biol Chem; 2002 Sep; 277(38):35616-24. PubMed ID: 12105230 [TBL] [Abstract][Full Text] [Related]
19. Immunoaffinity purification of protein C by using conformation-specific monoclonal antibodies to protein C-calcium ion complex. Nakamura S; Sakata Y Biochim Biophys Acta; 1987 Aug; 925(2):85-93. PubMed ID: 3620498 [TBL] [Abstract][Full Text] [Related]
20. Localization of the specific binding site for magnesium(II) ions in factor IX. Sekiya F; Yoshida M; Yamashita T; Morita T FEBS Lett; 1996 Sep; 392(3):205-8. PubMed ID: 8774845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]